These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23865934)

  • 1. trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16-F10 cells: cytotoxicity and phototoxicity.
    Gomes AJ; Espreafico EM; Tfouni E
    Mol Pharm; 2013 Oct; 10(10):3544-54. PubMed ID: 23865934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. trans-[Ru(NO)(NH3)4(py)](BF4)3.H2O encapsulated in PLGA microparticles for delivery of nitric oxide to B16-F10 cells: Cytotoxicity and phototoxicity.
    Gomes AJ; Barbougli PA; Espreafico EM; Tfouni E
    J Inorg Biochem; 2008 Apr; 102(4):757-66. PubMed ID: 18215422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of an NO photoinduced releaser xerogel based on the controlled nitric oxide donor trans-[Ru(NO)Cl(cyclam)](PF6)2 (cyclam=1,4,8,11-tetraazacyclotetradecane).
    Ferreira KQ; Schneider JF; Nascente PA; Rodrigues-Filho UP; Tfouni E
    J Colloid Interface Sci; 2006 Aug; 300(2):543-52. PubMed ID: 16780861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B; Ranganathan B; Feng SS
    Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable polymeric system for cisplatin delivery: development, in vitro characterization and investigation of toxicity profile.
    Alam N; Khare V; Dubey R; Saneja A; Kushwaha M; Singh G; Sharma N; Chandan B; Gupta PN
    Mater Sci Eng C Mater Biol Appl; 2014 May; 38():85-93. PubMed ID: 24656356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
    Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A
    Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity, photolability, and computational studies of the ruthenium nitrosyl complex with a substituted cyclam fac-[Ru(NO)Cl2(κ3N4,N8,N11(1-carboxypropyl)cyclam)]Cl·H2O.
    Doro FG; Pepe IM; Galembeck SE; Carlos RM; da Rocha ZN; Bertotti M; Tfouni E
    Dalton Trans; 2011 Jun; 40(24):6420-32. PubMed ID: 21584321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
    Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
    Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide.
    Taha MA; Singh SR; Dennis VA
    Nanotechnology; 2012 Aug; 23(32):325101. PubMed ID: 22824940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
    Saxena V; Sadoqi M; Shao J
    Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The macrocyclic effect and vasodilation response based on the photoinduced nitric oxide release from trans-[RuCl(tetraazamacrocycle)NO](2+).
    Oliveira Fde S; Ferreira KQ; Bonaventura D; Bendhack LM; Tedesco AC; Machado Sde P; Tfouni E; da Silva RS
    J Inorg Biochem; 2007 Feb; 101(2):313-20. PubMed ID: 17141326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled NO-releasing compound: synthesis, molecular structure, spectroscopy, electrochemistry, and chemical reactivity of R,R,S,S-trans-[RuCl(NO)(cyclam)]2+(1,4,8,11-tetraazacyclotetradecane).
    Lang DR; Davis JA; Lopes LG; Ferro AA; Vasconcellos LC; Franco DW; Tfouni E; Wieraszko A; Clarke MJ
    Inorg Chem; 2000 May; 39(11):2294-300. PubMed ID: 12526488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sub-unit vaccine against S. aureus-mediated infections: set-up of nano-sized polymeric adjuvant.
    Colonna C; Dorati R; Conti B; Caliceti P; Genta I
    Int J Pharm; 2013 Aug; 452(1-2):390-401. PubMed ID: 23707885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation.
    Marquele-Oliveira F; Santana DC; Taveira SF; Vermeulen DM; de Oliveira AR; da Silva RS; Lopez RF
    J Pharm Biomed Anal; 2010 Dec; 53(4):843-51. PubMed ID: 20634015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.
    Molavi O; Mahmud A; Hamdy S; Hung RW; Lai R; Samuel J; Lavasanifar A
    Mol Pharm; 2010 Apr; 7(2):364-74. PubMed ID: 20030320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.